Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncol (Q37117099)

From Wikidata
Jump to navigation Jump to search
scientific article published on 27 October 2008
edit
Language Label Description Also known as
English
Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncol
scientific article published on 27 October 2008

    Statements

    Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncol (English)
    Kouros Owzar
    Christopher L Corless
    Donna Hollis
    Ernest C Borden
    Christopher D M Fletcher
    Christopher W Ryan
    Charles D Blanke
    Cathryn Rankin
    Robert S Benjamin
    Vivien H Bramwell
    Jonathan A Fletcher
    27 October 2008
    5360-5367

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit